Genscript Biotech Corporation (FRA:G51)
1.625
-0.009 (-0.55%)
At close: Dec 5, 2025
24.05% (1Y)
| Market Cap | 3.63B |
| Revenue (ttm) | 705.13M |
| Net Income (ttm) | 2.65B |
| Shares Out | n/a |
| EPS (ttm) | 1.20 |
| PE Ratio | 1.37 |
| Forward PE | 39.54 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 15 |
| Open | 1.625 |
| Previous Close | 1.634 |
| Day's Range | 1.625 - 1.625 |
| 52-Week Range | 1.100 - 2.042 |
| Beta | n/a |
| RSI | 43.78 |
| Earnings Date | n/a |